Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Equity (Unaudited)

v3.20.1
Condensed Consolidated Statements of Changes in Equity (Unaudited) - USD ($)
Preferred Stock
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Deficit
Statutory Reserve
Accumulated Other Comprehensive Loss
Non-controlling Interest
Total
Beginning balance at Dec. 31, 2018 $ 7,383 $ 24,153,378 $ (522,500) $ (11,291,776) $ 6,578 $ (236,860) $ (862,200) $ 11,254,003
Beginning balance, Shares at Dec. 31, 2018 73,830,751   (520,000)          
Issuance of common stock upon cashless exercise of stock warrants $ 35 (35)  
Issuance of common stock upon cashless exercise of stock warrants, Shares 350,856    
Issuance of common stock upon cashless exercise of stock options $ 16 (16)  
Issuance of common stock upon cashless exercise of stock options, Shares 158,932    
Stock-based compensation 2,272,747 2,272,747
Foreign currency translation adjustment 44,680 (1,198) 43,482
Net loss (4,405,816) (99,113) (4,504,929)
Ending balance at Mar. 31, 2019 $ 7,434 26,426,074 $ (522,500) (15,697,592) 6,578 (192,180) 962,511 9,065,303
Ending balance, Shares 74,340,539   (520,000)          
Beginning balance at Dec. 31, 2019 $ 7,673 34,593,006 $ (522,500) (29,361,937) 6,578 (257,747) 4,465,073
Beginning balance, Shares at Dec. 31, 2019 76,730,802   (520,000)          
Sale of common stock, net $ 98 1,539,153 1,539,251
Sale of common stock, net, Shares 980,358            
Issuance of common stock for services $ 22 213,278 213,300
Issuance of common stock for services, Shares 222,577            
Stock-based compensation 785,350 785,350
Foreign currency translation adjustment (22,066) (22,066)
Net loss (3,270,781) (3,270,781)
Ending balance at Mar. 31, 2020 $ 7,793 $ 37,130,787 $ (522,500) $ (32,632,718) $ 6,578 $ (279,813) $ 3,710,127
Ending balance, Shares 77,933,737   (520,000)